# Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer

> **NCT06068738** · — · TERMINATED · sponsor: **Exscientia AI Limited** · enrollment: 13 (actual)

## Conditions studied

- Epithelial Ovarian Cancer

## Interventions

- **OTHER:** Biological sample collection

## Key facts

- **NCT ID:** NCT06068738
- **Lead sponsor:** Exscientia AI Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-04-14
- **Primary completion:** 2024-08-14
- **Final completion:** 2024-08-14
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Study was terminated due to a strategic re-evaluation of the company's overall business and clinical development strategy.
- **Last updated:** 2024-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06068738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06068738, "Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT06068738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*